+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Liver Cancer Diagnostics Market Size, Share & Trends Analysis Report by Test Type (Laboratory Tests, Imaging, Endoscopy, Biopsy), End-use (Hospitals & Diagnostic Laboratories, Pharmaceutical & CRO Laboratories), and Region with Growth Forecasts, 2025-2030- Product Image
Liver Cancer Diagnostics Market Size, Share & Trends Analysis Report by Test Type (Laboratory Tests, Imaging, Endoscopy, Biopsy), End-use (Hospitals & Diagnostic Laboratories, Pharmaceutical & CRO Laboratories), and Region with Growth Forecasts, 2025-2030- Product Image
New

Liver Cancer Diagnostics Market Size, Share & Trends Analysis Report by Test Type (Laboratory Tests, Imaging, Endoscopy, Biopsy), End-use (Hospitals & Diagnostic Laboratories, Pharmaceutical & CRO Laboratories), and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 150 Pages
  • May 2025
  • Region: Global
  • Grand View Research
  • ID: 4751806
Description Jump to:
The Liver Cancer Diagnostics Market was valued at USD 9.99 billion in 2024, and is projected to reach USD 14.67 billion by 2030, rising at a CAGR of 6.67%. The growing prevalence of liver cancer, the technological advancements for diagnosis, and the awareness of screening importance for treatment & survival rate are driving the market growth for liver cancer diagnostics.

According to the American Society of Cancer statistics in 2022, around 41,260 new cases are expected to be diagnosed with liver cancer. It was also presented by Globocan in 2020, that about 830,180 deaths were accounted by liver cancer worldwide. WHO also estimates that chronic hepatitis viral infections are widespread in the population, with hepatitis C virus (HCV) affecting about 58 million people. HCV and hepatitis B virus (HBV) are the most commonly associated risk factors of liver cancer. In addition, the infection prevalence and exposure to other risk factors such as cirrhosis and smoking will upsurge the demand for screening solutions for early treatment & diagnosis of liver cancer to increase the survival rate. Thus, the demand for diagnostics products will boost during the forecast period, thereby driving market growth.

The COVID-19 pandemic disrupted liver cancer patient care and resulted in higher mortality rates. The delayed or interrupted screening & procedures impacted the patients with the disease. For example, in a June 2021 article, researchers from European countries assessed the pandemic’s impact on routine care of liver cancer patients and concluded that the modifications significantly altered the outcomes. However, with advancements in technology and a better understanding of the immune system during COVID-19, many new healthcare diagnostic products have been launched. Moreover, the pandemic boosted the importance of health and pushed the population toward regular health screening for early diagnosis & treatment.

The technological advancement in diagnosis has resulted from increased awareness and supportive initiatives by many public-private organizations worldwide. This will result in a conducive environment to increase the screening as well as diagnosis of various cancers and is expected to propel the growth of diagnostics solutions. For example, in September 2022, Delfi Diagnostics, Inc., a U.S.-based diagnostics company, announced that it has been selected as the liquid biopsy partner in a large-scale screening trial in Europe.

To cater to the increased demand for innovative solutions for the early detection of liver cancer, multiple companies are launching new products. For instance, in March 2020, F. Hoffmann-La Roche Ltd. Roche received the ‘Breakthrough Device Designation’ from the US FDA for its new Elecsys GALAD score. The score supports clinicians in the diagnosis of hepatocellular carcinoma (HCC) by providing them with timely and accurate information. Key companies are also undergoing collaborations, agreements, and partnerships for new product developments. Such product developments & launches will intensify the market competition and fuel the market growth for liver cancer diagnostics.

Liver Cancer Diagnostics Market Report Highlights

  • On the basis of test type, laboratory tests held the largest share in 2024, owing to the increased demand for accurate & cost-effective diagnosis of disease stages. In addition, the application of laboratory tests for monitoring response to treatment plans also propels the growth
  • Based on end-use, the hospitals and diagnostic laboratories segment dominated the market in 2024. The preference for these settings as primary care centers for the diagnosis and treatment with the help of medical professionals boosts the segment’s growth
  • North America accounted for the highest share in 2024, due to the prevalence of risk factors in the population. This has resulted from the increased awareness about disease screening and the growing adoption of advanced technologies in this region, driving the growth
  • Asia-Pacific will exhibit the fastest CAGR during the forecast period, owing to the prevalence of diseases and the presence of a large geriatric population in the region. In addition, the developing economies will boost the adoption of diagnostic tests in the region’s emerging countries.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Test type
1.2.2. End Use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Test type outlook
2.2.2. End Use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Liver Cancer Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing Incidence of Liver Cancer
3.2.1.2. Technological Advancements
3.2.1.3. Extensive R&D For Developing Novel Testing Solutions
3.2.2. Market restraint analysis
3.2.2.1. High Cost of Diagnostic imaging
3.3. Liver Cancer Diagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
Chapter 4. Liver Cancer Diagnostics Market: Test type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Liver Cancer Diagnostics Market: Product Movement Analysis
4.3. Liver Cancer Diagnostics Market Size & Trend Analysis, by test type, 2018 to 2030 (USD Million)
4.3.1. Global Laboratory Tests Market, 2018-2030 (USD Million)
4.3.1.1. Biomarkers
4.3.1.1.1. Global biomarkers market, 2018-2030 (USD Million)
4.3.1.1.1.1. Oncofetal and Glycoprotein Antigens
4.3.1.1.1.1.1. Global oncofetal and glycoprotein antigens market, 2018-2030 (USD Million)
4.3.1.1.1.2. Enzymes and Isoenzymes
4.3.1.1.1.2.1. Global enzymes and isoenzymes market, 2018-2030 (USD Million)
4.3.1.1.1.3. Growth Factors and Receptors
4.3.1.1.1.3.1. Global growth factors and receptors market, 2018-2030 (USD Million)
4.3.1.1.1.4. Molecular Markers
4.3.1.1.1.4.1. Global molecular markers market, 2018-2030 (USD Million)
4.3.1.1.1.5. Pathological Biomarkers
4.3.1.1.1.5.1. Global pathological biomarkers market, 2018-2030 (USD Million)
4.3.1.2. Blood Tests
4.3.1.2.1. Global blood tests market, 2018-2030 (USD Million)
4.3.2. Imaging
4.3.2.1. Global Imaging Market, 2018-2030 (USD Million)
4.3.3. Endoscopy
4.3.3.1. Global Endoscopy Market, 2018-2030 (USD Million)
4.3.4. Biopsy
4.3.4.1. Global Biopsy Market, 2018-2030 (USD Million)
Chapter 5. Liver Cancer Diagnostics Market: End Use Estimates & Trend Analysis
5.1. End Use Market Share, 2024 & 2030
5.2. Segment Dashboard
5.3. Global Liver Cancer Diagnostics Market by End Use Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Hospitals & Diagnostic Laboratories
5.5.1. Global Hospitals & Diagnostic Laboratories market, 2018-2030 (USD Million)
5.6. Academic & Research Institutes
5.6.1. Global Academic & Research Institutes Market, 2018-2030 (USD Million)
5.7. Pharmaceutical & CRO Laboratories
5.7.1. Global Pharmaceutical & CRO Laboratories market, 2018-2030 (USD Million)
Chapter 6. Liver Cancer Diagnostics Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
6.5. North America
6.5.1. North America: SWOT Analysis
6.5.2. U.S.
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/Reimbursement
6.5.2.3. Competitive scenario
6.5.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
6.5.3. Canada
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/Reimbursement
6.5.3.3. Competitive scenario
6.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.5.4. Mexico
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework/Reimbursement
6.5.4.3. Competitive scenario
6.5.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Europe
6.6.1. Europe: SWOT Analysis
6.6.2. UK
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/Reimbursement
6.6.2.3. Competitive scenario
6.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
6.6.3. Germany
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/Reimbursement
6.6.3.3. Competitive scenario
6.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
6.6.4. France
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework/Reimbursement
6.6.4.3. Competitive scenario
6.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
6.6.5. Italy
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework/Reimbursement
6.6.5.3. Competitive scenario
6.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
6.6.6. Spain
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework/Reimbursement
6.6.6.3. Competitive scenario
6.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
6.6.7. Norway
6.6.7.1. Key country dynamics
6.6.7.2. Regulatory framework/Reimbursement
6.6.7.3. Competitive scenario
6.6.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
6.6.8. Sweden
6.6.8.1. Key country dynamics
6.6.8.2. Regulatory framework/Reimbursement
6.6.8.3. Competitive scenario
6.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
6.6.9. Denmark
6.6.9.1. Key country dynamics
6.6.9.2. Regulatory framework/Reimbursement
6.6.9.3. Competitive scenario
6.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Asia Pacific
6.7.1. Asia Pacific: SWOT Analysis
6.7.2. Japan
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/Reimbursement
6.7.2.3. Competitive scenario
6.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
6.7.3. China
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/Reimbursement
6.7.3.3. Competitive scenario
6.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
6.7.4. India
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/Reimbursement
6.7.4.3. Competitive scenario
6.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
6.7.5. Australia
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework/Reimbursement
6.7.5.3. Competitive scenario
6.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
6.7.6. South Korea
6.7.6.1. Key country dynamics
6.7.6.2. Regulatory framework/Reimbursement
6.7.6.3. Competitive scenario
6.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
6.7.7. Thailand
6.7.7.1. Key country dynamics
6.7.7.2. Regulatory framework/Reimbursement
6.7.7.3. Competitive scenario
6.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
6.8. Latin America
6.8.1. Latin America: SWOT Analysis
6.8.2. Brazil
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework/Reimbursement
6.8.2.3. Competitive scenario
6.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
6.8.3. Argentina
6.8.3.1. Key country dynamics
6.8.3.2. Regulatory framework/Reimbursement
6.8.3.3. Competitive scenario
6.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
6.9. MEA
6.9.1. MEA: SWOT Analysis
6.9.2. South Africa
6.9.2.1. Key country dynamics
6.9.2.2. Regulatory framework/Reimbursement
6.9.2.3. Competitive scenario
6.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
6.9.3. Saudi Arabia
6.9.3.1. Key country dynamics
6.9.3.2. Regulatory framework/Reimbursement
6.9.3.3. Competitive scenario
6.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
6.9.4. UAE
6.9.4.1. Key country dynamics
6.9.4.2. Regulatory framework/Reimbursement
6.9.4.3. Competitive scenario
6.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
6.9.5. Kuwait
6.9.5.1. Key country dynamics
6.9.5.2. Regulatory framework
6.9.5.3. Competitive scenario
6.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2024
7.3.4. Abbott Laboratories
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Services benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Thermo Fisher Scientific, Inc.
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Services benchmarking
7.3.5.4. Strategic initiatives
7.3.6. F. Hoffmann-La Roche Ltd.
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Services benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Qiagen N.V.
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Services benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Siemens Healthineers
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Services benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Becton, Dickinson & Company
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Services benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Illumina, Inc.
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Services benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Epigenomics AG
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Services benchmarking
7.3.11.4. Strategic initiatives
7.3.12. Koninklijke Philips N.V.
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Services benchmarking
7.3.12.4. Strategic initiatives
7.3.13. Fujifilm Medical Systems U.S.A., Inc.
7.3.13.1. Company overview
7.3.13.2. Financial performance
7.3.13.3. Services benchmarking
7.3.13.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 North America Liver cancer diagnostics market, by region, 2018-2030 (USD Million)
Table 3 North America Liver cancer diagnostics market, by test type, 2018-2030 (USD Million)
Table 4 North America Liver cancer diagnostics market, by end user, 2018-2030 (USD Million)
Table 5 U.S Liver cancer diagnostics market, by test type, 2018-2030 (USD Million)
Table 6 U.S Liver cancer diagnostics market, by end user, 2018-2030 (USD Million)
Table 7 Canada Liver cancer diagnostics market, by test type, 2018-2030 (USD Million)
Table 8 Canada Liver cancer diagnostics market, by end user, 2018-2030 (USD Million)
Table 9 Mexico Liver cancer diagnostics market, by test type, 2018-2030 (USD Million)
Table 10 Mexico Liver cancer diagnostics market, by end user, 2018-2030 (USD Million)
Table 11 Europe Liver cancer diagnostics market, by test type, 2018-2030 (USD Million)
Table 12 Europe Liver cancer diagnostics market, by end user, 2018-2030 (USD Million)
Table 13 UK Liver cancer diagnostics market, by test type, 2018-2030 (USD Million)
Table 14 UK Liver cancer diagnostics market, by end user, 2018-2030 (USD Million)
Table 15 Germany Liver cancer diagnostics market, by test type, 2018-2030 (USD Million)
Table 16 Germany Liver cancer diagnostics market, by end user, 2018-2030 (USD Million)
Table 17 France Liver cancer diagnostics market, by test type, 2018-2030 (USD Million)
Table 18 France Liver cancer diagnostics market, by end user, 2018-2030 (USD Million)
Table 19 Italy Liver cancer diagnostics market, by test type, 2018-2030 (USD Million)
Table 20 Italy Liver cancer diagnostics market, by end user, 2018-2030 (USD Million)
Table 21 Spain Liver cancer diagnostics market, by test type, 2018-2030 (USD Million)
Table 22 Spain Liver cancer diagnostics market, by end user, 2018-2030 (USD Million)
Table 23 Denmark Liver cancer diagnostics market, by test type, 2018-2030 (USD Million)
Table 24 Denmark Liver cancer diagnostics market, by end user, 2018-2030 (USD Million)
Table 25 Sweden Liver cancer diagnostics market, by test type, 2018-2030 (USD Million)
Table 26 Sweden Liver cancer diagnostics market, by end user, 2018-2030 (USD Million)
Table 27 Norway Liver cancer diagnostics market, by test type, 2018-2030 (USD Million)
Table 28 Norway Liver cancer diagnostics market, by end user, 2018-2030 (USD Million)
Table 29 Asia Pacific Liver cancer diagnostics market, by test type, 2018-2030 (USD Million)
Table 30 Asia Pacific Liver cancer diagnostics market, by end user, 2018-2030 (USD Million)
Table 31 Japan Liver cancer diagnostics market, by test type, 2018-2030 (USD Million)
Table 32 Japan Liver cancer diagnostics market, by end user, 2018-2030 (USD Million)
Table 33 China Liver cancer diagnostics market, by test type, 2018-2030 (USD Million)
Table 34 China Liver cancer diagnostics market, by end user, 2018-2030 (USD Million)
Table 35 India Liver cancer diagnostics market, by test type, 2018-2030 (USD Million)
Table 36 India Liver cancer diagnostics market, by end user, 2018-2030 (USD Million)
Table 37 Australia Liver cancer diagnostics market, by test type, 2018-2030 (USD Million)
Table 38 Australia Liver cancer diagnostics market, by end user, 2018-2030 (USD Million)
Table 39 South Korea Liver cancer diagnostics market, by test type, 2018-2030 (USD Million)
Table 40 South Korea Liver cancer diagnostics market, by end user, 2018-2030 (USD Million)
Table 41 Thailand Liver cancer diagnostics market, by test type, 2018-2030 (USD Million)
Table 42 Thailand Liver cancer diagnostics market, by end user, 2018-2030 (USD Million)
Table 43 Latin America Liver cancer diagnostics market, by test type, 2018-2030 (USD Million)
Table 44 Latin America Liver cancer diagnostics market, by end user, 2018-2030 (USD Million)
Table 45 Brazil Liver cancer diagnostics market, by test type, 2018-2030 (USD Million)
Table 46 Brazil Liver cancer diagnostics market, by end user, 2018-2030 (USD Million)
Table 47 Argentina Liver cancer diagnostics market, by test type, 2018-2030 (USD Million)
Table 48 Argentina Liver cancer diagnostics market, by end user, 2018-2030 (USD Million)
Table 49 MEA Liver cancer diagnostics market, by test type, 2018-2030 (USD Million)
Table 50 MEA Liver cancer diagnostics market, by end user, 2018-2030 (USD Million)
Table 51 South Africa Liver cancer diagnostics market, by test type, 2018-2030 (USD Million)
Table 52 South Africa Liver cancer diagnostics market, by end user, 2018-2030 (USD Million)
Table 53 Saudi Arabia Liver cancer diagnostics market, by test type, 2018-2030 (USD Million)
Table 54 Saudi Arabia Liver cancer diagnostics market, by end user, 2018-2030 (USD Million)
Table 55 UAE Liver cancer diagnostics market, by test type, 2018-2030 (USD Million)
Table 56 UAE Liver cancer diagnostics market, by end user, 2018-2030 (USD Million)
Table 57 Kuwait Liver cancer diagnostics market, by test type, 2018-2030 (USD Million)
Table 58 Kuwait Liver cancer diagnostics market, by end user, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Primary interviews in North America
Figure 5 Primary interviews in Europe
Figure 6 Primary interviews in APAC
Figure 7 Primary interviews in Latin America
Figure 8 Primary interviews in MEA
Figure 9 Market research approaches
Figure 10 Value-chain-based sizing & forecasting
Figure 11 QFD modeling for market share assessment
Figure 12 Market formulation & validation
Figure 13 Liver cancer diagnostics market: market outlook
Figure 14 Liver cancer diagnostics competitive insights
Figure 15 Parent market outlook
Figure 16 Related/ancillary market outlook
Figure 17 Penetration and growth prospect mapping
Figure 18 Industry value chain analysis
Figure 19 Liver cancer diagnostics market driver impact
Figure 20 Liver cancer diagnostics market restraint impact
Figure 21 Liver cancer diagnostics market strategic initiatives analysis
Figure 22 Liver cancer diagnostics market: Test type movement analysis
Figure 23 Liver cancer diagnostics market: Test type outlook and key takeaways
Figure 24 Laboratory Tests Liver Cancer Diagnostics market estimates and forecast, 2018-2030
Figure 25 Imaging Liver Cancer Diagnostics estimates and forecast, 2018-2030
Figure 26 Endoscopy Liver Cancer Diagnostics market estimates and forecast, 2018-2030
Figure 27 Biopsy Liver Cancer Diagnostics market estimates and forecast, 2018-2030
Figure 28 Liver cancer diagnostics market: End-use movement analysis
Figure 29 Liver cancer diagnostics market: End-use outlook and key takeaways
Figure 30 Hospitals & Diagnostic Laboratories market estimates and forecasts, 2018-2030
Figure 31 Academic and Research Institutes market estimates and forecasts, 2018-2030
Figure 32 Pharmaceutical & CRO Laboratories market estimates and forecasts, 2018-2030
Figure 33 Global Liver cancer diagnostics market: Regional movement analysis
Figure 34 Global Liver cancer diagnostics market: Regional outlook and key takeaways
Figure 35 Global Liver cancer diagnostics market share and leading players
Figure 36 North America market share and leading players
Figure 37 Europe market share and leading players
Figure 38 Asia Pacific market share and leading players
Figure 39 Latin America market share and leading players
Figure 40 Middle East & Africa market share and leading players
Figure 41 North America: SWOT
Figure 42 Europe SWOT
Figure 43 Asia Pacific SWOT
Figure 44 Latin America SWOT
Figure 45 MEA SWOT
Figure 46 North America, by country
Figure 47 North America
Figure 48 North America market estimates and forecasts, 2018-2030
Figure 49 U.S.
Figure 50 U.S. market estimates and forecasts, 2018-2030
Figure 51 Canada
Figure 52 Canada market estimates and forecasts, 2018-2030
Figure 53 Mexico
Figure 54 Mexico market estimates and forecasts, 2018-2030
Figure 55 Europe
Figure 56 Europe market estimates and forecasts, 2018-2030
Figure 57 UK
Figure 58 UK market estimates and forecasts, 2018-2030
Figure 59 Germany
Figure 60 Germany market estimates and forecasts, 2018-2030
Figure 61 France
Figure 62 France market estimates and forecasts, 2018-2030
Figure 63 Italy
Figure 64 Italy market estimates and forecasts, 2018-2030
Figure 65 Spain
Figure 66 Spain market estimates and forecasts, 2018-2030
Figure 67 Denmark
Figure 68 Denmark market estimates and forecasts, 2018-2030
Figure 69 Sweden
Figure 70 Sweden market estimates and forecasts, 2018-2030
Figure 71 Norway
Figure 72 Norway market estimates and forecasts, 2018-2030
Figure 73 Asia Pacific
Figure 74 Asia Pacific market estimates and forecasts, 2018-2030
Figure 75 China
Figure 76 China market estimates and forecasts, 2018-2030
Figure 77 Japan
Figure 78 Japan market estimates and forecasts, 2018-2030
Figure 79 India
Figure 80 India market estimates and forecasts, 2018-2030
Figure 81 Thailand
Figure 82 Thailand market estimates and forecasts, 2018-2030
Figure 83 South Korea
Figure 84 South Korea market estimates and forecasts, 2018-2030
Figure 85 Australia
Figure 86 Australia market estimates and forecasts, 2018-2030
Figure 87 Latin America
Figure 88 Latin America market estimates and forecasts, 2018-2030
Figure 89 Brazil
Figure 90 Brazil market estimates and forecasts, 2018-2030
Figure 91 Argentina
Figure 92 Argentina market estimates and forecasts, 2018-2030
Figure 93 Middle East and Africa
Figure 94 Middle East and Africa market estimates and forecasts, 2018-2030
Figure 95 South Africa
Figure 96 South Africa market estimates and forecasts, 2018-2030
Figure 97 Saudi Arabia
Figure 98 Saudi Arabia market estimates and forecasts, 2018-2030
Figure 99 UAE
Figure 100 UAE market estimates and forecasts, 2018-2030
Figure 101 Kuwait
Figure 102 Kuwait market estimates and forecasts, 2018-2030
Figure 103 Market share of key market players- Liver cancer diagnostics market

Companies Mentioned

The major companies featured in this Liver Cancer Diagnostics market report include:
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Qiagen N.V.
  • Siemens Healthineers
  • Becton, Dickinson & Company
  • Illumina, Inc.
  • Epigenomics AG
  • Koninklijke Philips N.V.
  • Fujifilm Medical Systems U.S.A., Inc.

Table Information

Report AttributeDetails
No. of Pages150
PublishedMay 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 9.99 Billion
Forecasted Market Value ( USD ) by 2030 $ 14.67 Billion
Compound Annual Growth Rate6.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Liver Cancer Diagnostics Market by Disease Stage, End User, Test Type, Technology - Global Forecast to 2030 - Product Image

Liver Cancer Diagnostics Market by Disease Stage, End User, Test Type, Technology - Global Forecast to 2030

  • Report
  • 186 Pages
  • Global
From
Liver Disease Diagnostics Market Size, Share and Trends Analysis Report by Diagnosis Technique (Imaging, Laboratory Tests, Endoscopy, Biopsy), Disease (NAFLD, NASH, Fibrosis, Cirrhosis), End-use (Hospitals, Laboratories), and Region 2024-2030 - Product Image

Liver Disease Diagnostics Market Size, Share and Trends Analysis Report by Diagnosis Technique (Imaging, Laboratory Tests, Endoscopy, Biopsy), Disease (NAFLD, NASH, Fibrosis, Cirrhosis), End-use (Hospitals, Laboratories), and Region 2024-2030

  • Report
  • 80 Pages
  • Global
From
Liver Cancer Diagnostics - Global Strategic Business Report - Product Image

Liver Cancer Diagnostics - Global Strategic Business Report

  • Report
  • 88 Pages
  • Global
From
Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Type (IVD, LDT, Imaging), By Application (Breast Cancer, Lung Cancer), By End-use, By Test Type, By Coverage, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Type (IVD, LDT, Imaging), By Application (Breast Cancer, Lung Cancer), By End-use, By Test Type, By Coverage, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 200 Pages
  • Global
From
Cancer Diagnostics Market by Diagnostic Type, Application, Regional Outlook - Global Forecast up to 2030 - Product Image

Cancer Diagnostics Market by Diagnostic Type, Application, Regional Outlook - Global Forecast up to 2030

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.